OmniAb (OABI) Other Non-Current Assets (2021 - 2026)
OmniAb (OABI) reported Other Non-Current Assets of $795000.0 for Q1 2026, down 37.99% year-over-year from $1.3 million in Q1 2025, and up 41.96% quarter-over-quarter from $560000.0 in Q4 2025.
OmniAb (OABI) Other Non-Current Assets (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Other Non-Current Assets data on file, last reported at $795000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $795000.0, down 37.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $795000.0 (down 37.99% YoY), and the FY2025 annual result was $560000.0, changed 0.0% from the prior year.
- Other Non-Current Assets climbed to $795000.0 in Q1 2026 per OABI's latest filing, from $560000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $3.3 million in Q2 2023 and troughed at $560000.0 in Q2 2024.
- A 5-year average of $1.8 million and a median of $1.5 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 109.22% in 2022, then plunged 83.26% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $3.1 million in 2022, then sank by 30.19% to $2.2 million in 2023, then plunged by 74.37% to $560000.0 in 2024, then changed by 0.0% to $560000.0 in 2025, then surged by 41.96% to $795000.0 in 2026.
- Business Quant data shows OABI's Other Non-Current Assets at $795000.0 in Q1 2026, $560000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 795,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 795,000.00 |
| Dec 31, 2025 | 560,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 3.19 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Jun 30, 2021 | 597,270.00 |